Evaluate whether nanopore whole-genome sequencing with adaptive sampling (AS-WGS) can detect clinically relevant genomic alterations and support tumor classification in pediatric cancers.
Approach:
Study samples: Researchers analyzed 36 samples from 35 pediatric patients, including 31 tumor samples from patients with leukemia and solid cancers.
Sequencing and analysis: Nanopore whole-genome sequencing with adaptive sampling (AS-WGS) targeted approximately 380 clinically relevant genomic regions while retaining genome-wide information. The team developed the open-source nf-core-oncoseq pipeline to analyze data during sequencing.
Comparison: The researchers compared AS-WGS results with conventional diagnostic testing and used DNA methylation information for tumor classification.
Key Findings:
Compared with conventional diagnostic testing, AS-WGS detected all 20 previously identified gene fusions, mutations in 58 of 59 affected genes, and 20 of 21 large copy-number alterations.
The assay detected mutations present in as little as 5% of sequenced DNA.
Within 24 hours, all 20 gene fusions and all 47 evaluated mutations with variant allele frequencies above 25% had at least five supporting reads. Large chromosomal alterations could be identified within the first hour.
Methylation-based analysis correctly classified 9 of 11 acute lymphoblastic leukemia samples and 8 of 12 solid tumors.
Researchers estimated sequencing costs at approximately CAD $1,700 per sample, compared with more than CAD $5,000 for combined conventional approaches.
Interpretation:
The study authors reported that AS-WGS provided early findings on clinically relevant alterations and combined detection of major genomic alteration classes with methylation-based tumor classification in one workflow.
Limitations:
Some variants required manual review, and low-frequency mutation detection could require 72 hours of sequencing.
DNA quality and sequencing performance affected results.
Further clinical validation is needed to determine whether AS-WGS can replace existing diagnostic workflows and improve treatment decisions.
Conclusion:
In this pediatric cancer sample set, AS-WGS detected many clinically relevant genomic alterations, with some findings available within hours, and supported methylation-based tumor classification.
UK pilot study finds that whole genome sequencing can uncover genetic conditions in children, leading to changes in clinical management and specialist care
New filtration technique detects low concentrations of bacteria and assesses antibiotic susceptibility, offering a potential faster route to diagnosing sepsis and other serious infections